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Abstract.  At the aggregation  stage of Dictyostelium 
discoideum development, a cell surface glycoprotein 
of Mr 80,000 (gp80) has been found to mediate the 
EDTA-resistant type of cell-cell adhesion via 
homophilic interaction  (Siu,  C.-H., A.  Cho, and 
A.  H. C.  Choi.  1987. J.  Cell Biol.  105:2523-2533). 
To investigate the structure-function relationships  of 
gp80,  we have isolated full length cDNA clones for 
gp80 and determined the DNA sequence.  The deduced 
structure of gp80 showed three major domains.  An 
amino-terminal  globular domain composed of the bulk 
of the protein is supported by a  short stalk region, 
which is followed by a membrane anchor at the car- 
boxy terminus.  Structural analysis suggested that the 
cell-binding domain of gp80 resides within the globu- 
lar domain near the amino terminus.  To investigate the 
relationship of the cell-binding activity to this region 
of the polypeptide, three protein A/gp80 (PA80) gene 
fusions were constructed using the expression vector 
pRIT2T.  These PA80 fusion proteins were assayed for 
their ability to bind to aggregation  stage cells. Binding 
of 125I-labeled fusion proteins PA80I (containing the 
Vail23 to Ile514 fragment of gp80) and PA80II  (Vail23 
to Ala258) was dosage dependent and could be in- 
hibited by precoating cells with the cell cohesion- 
blocking mAb 80L5C4.  On the other hand,  there was 
no appreciable binding of PA80III  (Ile174 to I1e514) to 
cells. Reassociation of cells was significantly inhibited 
in the presence of PA80I or PA80II.  In addition,  1251- 
labeled PA80II exhibited homophilic interaction with 
immobilized PA80I,  PA80II,  or gp80.  The results of 
these studies lead to the mapping of a cell-binding do- 
main in the region between VaU23  and Leu173 of 
gp80 and provide direct evidence that the cell-binding 
activity of gp80 resides in the protein moiety. 
URING development of the cellular slime  mold Dic- 
tyostelium  discoideum, solitary  cells migrate  in re- 
sponse to environmental  cAMP to form aggregates 
that eventually differentiate into fruiting bodies consisting of 
two major cell types: spores and stalk cells (Loomis, 1975). 
Multicellularity  during  development  is achieved by the ex- 
pression  of at  least two types of cell-cell  adhesion  sites 
(Gerisch, 1980). One type is sensitive to low concentrations 
of EDTA. These EDTA-sensitive binding sites are expressed 
on the cell surface soon after the initiation  of development 
(Knecht et al.,  1987; Siu et al.,  1988b).  Cells begin to ac- 
quire the EDTA-resistant  cell-cell binding  sites ,06 h later 
at the onset of the aggregation  stage (Rosen et al.,  1973). 
A membrane glycoprotein  of Mr 80,000 (gp80) has been 
implicated  in mediating the EDTA-resistant binding  sites by 
Muller  and  Gerisch  (1978). They  found  that  the  adhe- 
sion-blocking  activity  of a  univalent  polyclonal  antibody 
preparation  can be neutralized  by a highly  enriched gp80 
preparation.  Subsequently,  several polyclonal and monoclo- 
nal  antibodies  directed  against  gp80  have  been  reported 
(Murray et al.,  1981; Lam and  Siu,  1982; Ochiai  et al., 
1982a; Murray et al.,  1983; Springer and Barondes,  1985). 
Since they showed cross-reactivity with other glycoproteins, 
it has been difficult to use them to evaluate the role of gp80 
in cell-cell adhesion.  Recently, we succeeded in raising an 
mAb (80L5C4)  which is monospecific  for gp80 (Siu et al., 
1985). 80L5C4 IgG is also capable of inhibiting the EDTA- 
resistant  type of cell-cell adhesion  at the aggregation  stage 
of development,  thus  confirming  the role of gp80 in  cell 
adhesion (Siu et al., 1985). Purified gp80, when conjugated 
to Covaspheres,  can mediate the binding  of Covaspheres  to 
cells in a  stage-specific  manner  (Siu  et al.,  1987).  Also, 
gp80-conjugated  Covaspheres  associate preferentially  with 
the two polar ends  of streaming  cells and  with filopodia. 
Filopodia are transient  surface structures  characteristic  of 
aggregation  stage cells during  development  (De Chastellier 
and Ryter, 1980). Many can be observed making direct con- 
tacts with adjacent  cells,  and they have been implicated  in 
mediating  the initial stages of cell-cell adhesion  (Choi and 
Siu, 1987). These observations clearly establish that gp80 is 
a cell adhesion  molecule.  Moreover,  the binding of labeled 
gp80 or gp80-conjugated  Covaspheres  to cells can be in- 
hibited by precoating cells with 80L5C4 Fab, suggesting that 
gp80 mediates  cell-cell binding  via homophilic  interaction 
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in homophilic binding and the mechanism of homophilic in- 
teraction remain to be determined. 
Qualitative and quantitative binding studies indicate that 
80L5C4 IgG binds to a single epitope on gp80 (Siu et al., 
1985, 1988a). The 80L5C4 epitope is sensitive to proteolytic 
digestion, indicating that the antibody recognizes a region on 
the polypeptide (Siu et al., 1985, 1988a).  Recently, we have 
mapped the 80L5C4 epitope to a  protein region near the 
amino terminus of gp80  (Kamboj and Siu,  1988).  Since 
80L5C4 IgG is a potent inhibitor of cell-cell adhesion, it is 
likely that the cell binding site of gp80 is also located in a 
protein domain close to the 80L5C4 epitope. 
To investigate the structure-function relationships of gp80, 
we have constructed a ggtll expression library and cloned 
cDNAs for gp80 (Wong and Siu,  1986).  In this report, we 
determined the nucleotide sequence of a  full length gp80 
cDNA. Several different segments of the gp80 eDNA were 
cloned into an expression vector and fusion proteins were 
purified and assayed for their ability to bind to aggregation 
stage  cells and gp80  immobilized on  nitrocellulose.  The 
results of these studies confirm our prediction that the cell- 
binding  site of gp80  resides  in  the  close  vicinity of the 
80L5C4 epitope and led to the mapping of the cell-binding 
domain for the region near the amino terminus. 
Materials and Methods 
Cell Strain and Culture Conditions 
The wild-type strain NC4 of D.  discoideum  was used in all experiments. 
NC4 cells were cultured in association with Klebsiella  aerogenes and devel- 
oped as described (Sussman, 1966). Growth phase cells were collected from 
the partially cleared bacterial lawn, washed free of bacteria, and plated at 
2  x  l0  s cells/ml on filter paper (No. 50; Whatman Inc., Clifton, NJ) for 
development. Under these conditions, cells began to aggregate between 6 
and 8 h and aggregation was essentially complete by 12 h with the formation 
of round mounds. Culmination began at •18  h. Alternatively, cells were 
resuspended at 107 cells/ml in 17 mM Na2/K phosphate buffer, pH 6.4, and 
shaken at  180 rpm for development. 
Purification of  gp80 
gp80 was purified from the axenic strain AX2. AX2 cells were cultured in 
liquid medium as described by Cocucci and Sussman (1970) and then devel- 
oped in 17 mM phosphate buffer, pH 6.4, for 12 h, with cAMP pulsing (2 
x  10 -s M final concentration) at 7-min intervals. Cells were then collected 
and homogenized for gp80 isolation as described oreviously (Siu et al., 
1987).  Purified gp80 was stored either in lyophilized form or in solution 
at  -70°C. Samples were usually dialyzed against 0.1% octyl glucoside in 
PBS before use. 
cDNA Cloning 
A Lgtll expression library (Wong and Siu, 1986),  constructed from cDNA 
of aggregation stage cells using the method of Young and Davis (1983),  was 
used to screen for full length gp80 eDNA. We have previously characterized 
a cDNA clone ~,Ddgp80c-19,  which contains a  1.0-kb insert and encodes 
the amino-terminal portion of gp80. A Hae III to Eco RI fragment of 770 
bp derived from the ~,Ddgp80c-19 insert was used to screen the library.  Posi- 
tive recombinant phages were subjected to five cycles of  plaque purification. 
Three different recombinant phages, with two containing full length cDNA 
inserts, were isolated. The gp80 cDNA inserts were subeloned into the Eco 
RI site ofpEMBL18 (Dente et al., 1983).  DNA sequencing was performed 
for both strands using the dideoxy method of Sanger et al.  (1977). 
Construction of  Expression Vectors Containing 
gp80 cDNA Inserts 
Standard recombinant DNA methods were followed according to Maniatis 
et al. (1982).  gp80 cDNAs of different sizes were derived from the insert 
in the recombinant phage ~,Ddgp80-12.  This insert was sequenced in both 
directions and the DNA  sequence shows that  it  begins with the codon 
for Vail23 at the 5' end and has a 3' untranslated sequence of 101 bases. The 
first  gene  fusion  was  constructed  by  ligating  the  complete  insert  of 
LDdgp80-12  to the unique Eco RI site of the expression vector pRIT2T 
(Pharmacia Fine Chemicals Inc., Piscataway,  NJ) (see Fig. 2). The second 
one was constructed by fusing the Eco RI-Hind III fragment to the pRIT2T 
vector. In this case, the Hind III end was blunt-ended by either filling  in 
the ends with the Klenow fragment of DNA polymerase I or treatment with 
mungbean nuclease, followed by ligation to the Eco RI/Sma I site of  the vec- 
tor. Both constructs yielded identical results. To construct the third gene fu- 
sion, an Xmn I-Eco RI fragment was released from LDdgpS0-12 and ligated 
with an appropriate Eco RI linker at the 5' end before insertion into pRIT2T. 
The expression vector pRIT2T contains part of the coding sequence for pro- 
tein A and it is designed for temperature-inducible expression of fusion pro- 
teins in a suitable host cell, Escherichia  coli N4830-1,  which contains the 
temperature-sensitive ~,-cI857 repressor. When the temperature was shifted 
from 30 to 42°C, the repressor was inactivated and the LPR promoter was 
turned on, thus initiating the expression of fusion protein. Plasmids contain- 
ing gp80 eDNA inserts in the proper orientation were selected and ex- 
pressed. Lysates containing the fusion protein were analyzed by SDS-PAGE 
and immunoblotting using the mAb 80L5C4 or an anti-gp80 polyclonal an- 
tibody. 
Expression and Purification of  Protein A-gp80 
Fusion Proteins 
Plasmid DNA was used to transform the E. coli strain N4830-1.  Cells were 
grown at 30°C in the presence of ampicillin (50 p,g/ml) until OD600 =  1.0 
and the culture was shifted to 42°C by mixing the growth medium with an 
equal volume of medium preheated to 54°C. The culture was incubated at 
42°C  for 90 min before harvest. Cells were chilled immediately before 
collection. The cell pellet was resuspending in cold PBS containing 0.05% 
Tween-20, 2  mM EDTA, 0.5  mM phenylmethylsulfonyl fluoride, and  1 
~g/ml leupeptin. Cells were lysed by sonication and the sample was cen- 
trifuged at 25,000 g for 20 min. The supernatant was diluted fivefold with 
the same buffer minus EDTA before applying to an affinity column. Fusion 
proteins were usually purified by two passages through an IgG-Sepharose 
6FF affinity column (Pharmacia Fine Chemicals Inc.). Fusion proteins were 
elnted with 0.5 M acetic acid, pH 3.4.  Fractions containing fusion protein 
were neutralized with 0.5 M Na2HPO4, pooled, and dialyzed against PBS. 
To raise polyclonal antibodies against fusion proteins, 100 tag of purified 
fusion protein was emulsified with an equal volume of Freund's complete 
adjuvant and injected subcutaneously into New Zealand white rabbits. Ani- 
mals were boosted four times with 50 p.g of fusion protein emulsified in 
Freund's incomplete adjuvant at 2-wk intervals.  Serum samples were col- 
lected after the second boost. 
PAGE 
SDS-polyacrylamide slab gels were prepared according to Laemmli (1970). 
Protein samples were solubilized and reduced in 2% SDS, 8 M urea, and 
2% [3-mercaptoethanol  by boiling for 5 min. Electrophoresis was carried 
out using the minigel apparatus (Bio-Rad Laboratories, Richmond, CA) at 
a constant current of 20 mA for 40 rain. The following proteins were used 
as molecular mass markers: myosin (200 kD), phosphorylase B (97 kD), BSA 
(68 kD), ovalbumin (42 kD), and ct-chymotrypsinogen (25 kD). Gels were 
subjected to silver staining using the method of Morrissey (1981). 
Binding of  Fusion Proteins to Intact Cells 
Affinity-purified protein A/gp80 fusion proteins and gp80 were dialyzed 
against 0.1% octyl glucoside in PBS. Samples were radioiodinated using the 
chloramine T method, as previously described (Siu et al., 1977).  Different 
concentrations of the t25I-labeled protein were prepared in phosphate buf- 
fer immediately before addition to cell suspension, giving a final detergent 
concentration <0.005%. Cells were developed on filter pads for 10 h and 
then collected for the binding assay as previously described (Siu et al., 
1987). Cells were washed and resuspended in 17 mM phosphate buffer, pH 
6.4,  and resuspended at 5  ×  106 cells/ml in the same buffer plus 5 mM 
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ATG  AAA TTT TTA TTA GTA TTG  ATA ATA TTA TAT AAT  ATT TTA  AAT AGT GCA CAT TCA GCT CCA  ACA 
MET  Lya  phe  Leu  Leu  Val  Leu  lle  Ile  Leu  Tyr Aan  lie  LeU  Aan  Ser  Ala  His  See Ala  pro The 
TAT  ATT ACG  ATT  ACA GGT ACT GGA TTT  ACA GGA  ACT  CCA  GTT GTA ACT  ATT GGT GGC CAG ACC TGT 
Tyr  Ile  Thr  lle  The  Gly  The Gly phe  The Gly The  Pro  Val Val  Thr  Ile  Gly Gly Gln  Thr Cya 
CAA  TTT TCT GCT  CAA  TTA  GCT CCA GGA  AAT TCA AAT TTT GAT GTT ATT GTA  AAG GTT GGT GGT GTA 
Gln  phe  Ear Ala  Gin  Leu  Ala  Pro Gly  ASh  See ASh  Phe  Asp  Val  lle  Val  Lys Val  Gly Gly Val 
CCA ACT  CTT TCA  ACA ATA TTT  CCA AAT AAT GGA  AGA  ATT GGT ATG  ATT TTA[GTT  GAT GGA CCA  TCC 
Pro  The  Leu  Ser  Thr  Ile  Phe  pro  Asn  Asn  Gly  Arg  lle  Gly MET  lle  Leu]Val  Asp Gly pro See 
AAC TCT GCT ATG  TTA TCT GTT  ACT GCT GAT TeA GTA TCC CCA ACA ATT  TAT TTC CTC  GTG  CCA  AAT 
ASh  See  Ala  MET Leu See  Val  The Ala  Asp  Ear  Val  See  Pro  The  lle  Tyr  Phe  Leu  Val  pro  ASh 
-I 
ATA ACA GCT GTT TCA AAT GGA  AAA  TTT GGT GTT CCA  ACA  105 
lle  The  Ala  gal  See ASh  Gly  Lys  phe  Gly Val  Pro  The  35 
GAT CCA GTT ATT GTA GCC  AAT ACC GCA TCG TTA  CAA  TGC  210 
Asp Pro  Val  Ile  Val  Ala  ASh  The  Ala  See  Leu  Gln  Cys  70 
CCA TCT  ACA GGT GGT AAT GGT CTT TTT AAA TAT ACA  CCT  315 
pro  See  Thr Gly Gly Aan  GIy  Leu  Phe  Lys  Tyr  Thr  Pro  105 
! 
AAT ATA TCT GGA TAC AAA TTA  AAT GTG  AAC GAC TCT  ATTI  420 
Asn  lle  See Gly  Tyr  Lys Leu  Asn  Val  Asn  Asp See  lle I  140 
ACA ATC OCT 00T GGT CTA CTT AAT CTT GAA CTC  ATT CAA  525 
Thr  Ile  Ala  Gly Gly Leu  Leu  ASh  Leu  Glu Leu  Ile  Gln  175 
CCA TTT GGC  TTT TCA  ACA  ATT GTA ACT TCC  AAA  TCA GTG TTT TCT  CCA ACC  ATT ACA TCA ATC  ACC 
Pro  phe  Gly  Phe  See The  lle  Val  The See  Lys  See  Val  phe  See  Pro  The  lle  Thr  See  lle  The 
ACT GGT AAA  TAC TTT GTT ACT ACA GCT  AGT GTT  ACA ATG GGA  AGT CAT ATC  TAT  ACA GGA TTG  ACT 
The  Gly  Lys Tye  phe  Val  The  Thr Ala  See  Val  The MET Gly See  His  Ile  Tyr The  Gly  Leu  The 
ACT  CGT TCA GTT TAT GAA TCA TCA AAT  ACT ATA  ACT  GCT  AAA  GCT TCA ACA GGT GTC  GAT ATG  ATT 
The Arg  See  Val  Tyr  Glu See  See Asn  The  lie  The  Ala  Lys  Ala  See  Tnr  Gly Val  Asp MET lle 
ACA  TAT AAC CCA  CCA  ACC  ATT ACT TCA ACA AAA  CAA  GTC  AAT  GAC TCT GTT GAG ATC TCA ACA ACC 
The  Tye  ASh  pro  Pro  The  Ile  The See  The  Lya  Gln  Val  ASh  Asp  See  Val  Glu  Ile  See The The 
GGA  ACC  TCA AGC CCA ACA  AAC CTT GTA  ATC ACT GGT ACA  AAT  GAA  AAG ATT GTT ATA  ACT CTT CCA 
Gly The  See See  pro  Thr  ASh  Leu  Val  lle  The  Gly  The  Asn  Glu  Lys  Ile  Val  lle  The ieu  Pro 
GCT GGT ATC TCA AAT GTT GTC ACA TCA  ACT TTA TTA  GTT  ACT  CCG GTT  ATA  AAT AGT GTC ACT CAA 
Ala  Gly  Ile  See Asn  Val  Val  Tar See  The  Leu  Leu  Val  Thr  Pro  Val  Ile  Asn  Ser  Val  The Gln 
TTT TTA AAC  AAT GCC  CAT GTT TCG ATT GTT GTT GAC  CAA AAT ACT  ACT GAT ATA GTT TGT GCT CCA 
Phe  Ueu  Aan  Asn  Ala  Hls  Val  See  Ile  Val  Val  Asp  Gln  A~n  The  The  Asp  lie  Val  Cys  Ala  Pro 
GGT  AGT GGT ACT  ATT  AAT TTA  GTC GTT  AC~  ;/~C TAT  AAA AAC  TTT GCT  TCA  GAT CCA ACT ATT  AAA 
Gly See GIF  The  Ile  ASh  Leu  Val Val  The  ASh  Tyr  Lys  Asn  Phe  Ala  See Asp  Pro  The  Ile  Lys 
ACT CCA  ACT  CCA  ACT GAT  AGA  GCC ACC CCA  TCT CCA ACT CCA ACT GAA  AGA GCC ACC CCA TCT CCA 
The  Pro  The  pro  The  Asp  The  Ala  The  Pro See  Pro  The  Pro The  Glu The  Ala  The  Pro  See  Pro 
CCT TCA  TCA GCA  ACA  ACT CTT ATT TCA CCA  TTA  TGT  TTA  ATT GTT  ATT TTC  ATT TCT  TTT GTT TTA 
pro  See See Ala  The The  Leu  Ile  See  pro  Leu  See  Leu  lle  Val  lie  Phe  lie  See  Phe  Val  Leu 
CCA TTA GCT TTT GAT CTC  ACA  CCA ACC  AAT GTA  ACC GTC  630 
Pro  Leu  Ala  phe  Asp  Leo  The  pro  The  ASh  Val  The  Val  210 
GTT CAA GAT GAT GGA  ACA AAT TGT CAT GTT  ATT TTT  ACT  735 
Val  Oln  Asp  Asp Gly The ASh  Cys  His  Val  Ile  Phe  The  245 
TAT TTA GAC  AAT  CAA  GGT AAT CAA CAA  CCA  ATA ACT TTT  840 
Tyr  Leu  Asp  ASh  Gln  Gly ASh  Gln  Gln  Pro  Ile  The  Pne  280 
AAT ACT GGT ACT GAT TTC ACT CAA  ATT  TCT TTA ACC ATG  945 
ASh  The  Gly The Asp  phe  Thr  Gln  Ile  Ser  Leu  The MET  315 
CAT GCT CTT CCA GAA  GGT GAA  ATT CAA  TTC AAT TTG AAA  1050 
His  Ala  Leu  Pro  Glu  Gly Glu  Ile  Gin  Phe  Asn  Leu  Lys  350 
GCA CCT CAC AAT GGT 00A AGT  ATT  ACA  ATT TCA GGT ATC  1150 
Ala  pro  His  ASh  Gly Gly See  Ile  The  Ile  See  Gly  Ile  385 
GAT TCA AAT GGT GAA TCA ATC  ATT TGT  CCA  GTT GAA GCT  1260 
Asp See  ASh  GIy Glu  See  Ile  Ile  Cys  Pro  Val  Glu Ala  420 
ACT GAA GCC  ACA  ACC  TCT ACA ACC TAT  ACA ATT  CCA GAC  1365 
The Glu  Ala  The The  See The T~r Tye The  Ile  Pro Asp  455 
ACT CCA AAA  CCA ACC  AGC ACA  CCA GAA GAA ACT GAA GCA  1470 
The  Pro  Lys  Pro Thr  Ser The  pro  Glu Glu The  Glu Ala  490 
T  ~TA ATT  I  TAATTTAAATTAAATTATTTATATTAA~  1585 
Leu  Ile  514 
AAC  TCGCAATGTAATATTAAATAAATATAAAAATAAATAAGTG  TATTAACCTAT~  1716 
Figure 1.  Nucleotide  sequence  of the full  length eDNA  and the deduced  amino  acid  sequence  of gpS0.  Nucleotides  are numbered  at the 
right and labeled  positively  in the coding  and 3' untranslated  regions  and negatively  in the 5' untranslated  regions.  Amino  acids are also 
numbered  at  the  right.  The  arrow  under  Ala  at  amino  acid  position  20  marks  the  beginning  of the  mature  protein.  The  five  potential 
N-glycosylation  sites  are marked  by a  black dot.  The two  octapeptide  repeats  and  sequences  that  may  serve  as  polyadenylation  signals 
are  underlined.  The domain  containing  cell-binding  activity  is  boxed. 
EDTA. Samples of 0.1  ml were incubated with different  concentrations of 
J25I-labeled protein for 45 min at 4°C on a platform shaker. Unbound ma- 
terial was removed by washing twice with cold phosphate buffer.  As a con- 
trol,  cells were incubated  with similar concentrations of ~2SI-labeled pro- 
tein  A  and the amount  of bound  radioactivity  was  used  to  estimate  the 
nonspecific  background  binding  of  fusion  proteins.  Background  binding 
generally represented <5 % of the total amount of radioactive counts bound. 
Competition of  Fusion Protein Binding to 
Cells by mAbs 
10-h  cells were washed and resuspended  at 2  ×  107 cells/ml  in  17 mM 
phosphate buffer,  pH 6.4, containing 5 mM EDTA and then precoated with 
different  concentrations  of 80L5C4  IgG for  15  min  at  4°C.  Cells  were 
washed  once  and  resuspended  at  5  x  106  cells/ml  in  EDTA/phosphate 
buffer  containing 0.25 mg/ml goat anti-mouse IgG Fab (Cappel Laborato- 
ries, Inc., Cochranville,  PA) for 15 min at 4°C. Samples were briefly vor- 
texed before the addition of nsI-fusion protein, followed by a 45-rain incu- 
bation period at 4°C. 
Filter Binding Assay 
Fusion protein or gpS0 samples were immobilized on nitrocellulose disks, 
which were blocked with 5 % skim milk and 0.05 % Tween-20 in PBS. The 
disks were then  incubated  with different  amounts  of t25I-labeled  gp80 or 
fusion protein for 30 min at room temperature. Background binding was de- 
termined by the inclusion of a blank disk in the incubation mixture.  At the 
end of the incubation period, disks were washed with at least three changes 
of 5 % skim milk followed by two changes of 0.05 % Tween-20 in PBS. Disks 
were air dried and counted in a gamma counter. Background radioactivity 
was subtracted from the counts bound on the corresponding sample disk. 
Generally, it represented 25-35 % of the total amount of radioactivity bound 
on the sample disk. 
Competition experiments using fusion proteins were carded out by im- 
mobilizing  fixed amounts of gpS0 (0.1  lag) on nitrocellulose  disks, which 
were first blocked with 5% skim milk in PBS and 0.05%  Tween-20.  Then 
the disks were incubated with a mixture of nSI-labeled gpS0 and unlabeled 
fusion protein at different  molar ratios, with the concentration of the labeled 
gp80 kept constant at 200 ng/ml. Subsequent steps were identical to the as- 
say protocol. 
Cell Cohesion Assay 
Cell-cell adhesion was measured using a method modified from Gerisch's 
(1961)  roller tube assay (Lam et al.,  1981). Cells were dissociated and sus- 
pended at 2-3  x  106 cells/ml in 17 mM phosphate buffer,  pH 6.4, contain- 
ing  l0 mM  EDTA.  200-I.tl  samples were rotated  vertically on a platform 
shaker at  180 rpm.  Cells were counted at different  time intervals using a 
bemacytometer.  Both  singlets  and  doublets  were scored as unaggregated 
cells.  The percentage  of aggregated  cells was calculated  by dividing  the 
difference of the total number of cells and the number of single cells by the 
total number of cells. Cells were also reassociated in the presence of differ- 
ent concentrations  of fusion protein to assess the effect  of fusion  proteins 
on cell-cell  binding. 
To block cell reassociation with antibodies directed against fusion pro- 
tein, the method described by Springer and Barondes (1980) was used. Cells 
were suspended  at 2-3  ×  l07 cells/ml  in phosphate buffer  containing  l0 
mM EDTA and rabbit  anti-fusion  protein antiserum.  The sample was in- 
cubated at 4°C for 20 rain. Cells were vortexed briefly and diluted  1:10 in 
phosphate buffer containing l0 mM EDTA and goat anti-rabbit IgG Fab (0.5 
mg/ml) (Cappel Laboratories). Cells were incubated for another 10 min on 
ice and then vortexed briefly to dissociate the cells.  The sample was then 
rotated  on a platform shaker at 180 rpm at room temperature and the reas- 
sociation of cells was monitored microscopically  at regular intervals.  All 
experiments were repeated one to three times and almost identical  results 
were obtained  in all cases. 
Kamboj  et al.  Cell-binding Domain of gp80 in Dictyostelium  1837 Protein Determination 
Protein determination  was carried  out with the bicinchoninic  acid protein 
assay kit (Pierce  Chemical  Co., Rockford,  IL), using crystalline  BSA as the 
standard. 
Results 
cDNA Sequence and Deduced Structure of  gpSO 
Three recombinant phages carrying nearly full length cDNA 
inserts were isolated and characterized. The longest cDNA 
insert  was  sequenced in  both directions and  results  were 
confirmed  by  partial  sequences  obtained  from  the  other 
clones. A total of 1,820 bp were sequenced, containing a sin- 
gle open translational reading frame (Fig.  1). The 5' and 3' 
flanking regions are extremely AT rich and the initiation me- 
thionine codon is preceded by four A  nucleotides, charac- 
teristic of D.  discoideum translational  starts  (Kimmel and 
Firtel,  1983).  The coding region spans  1,542  nucleotides, 
terminating at a TAA codon. The 3' flanking region has two 
poly-A tracks. Two consensus polyadenylation signals (AAT- 
AAA) are situated 17 and 29 nucleotides upstream from the 
second poly-A track, suggesting that the second polyadeny- 
late tail  was  added posttranscriptionally whereas  the  first 
oligo-A track was transcribed from the gene. 
The open reading frame codes for a protein of 514 amino 
acids with Mr 53,703  (Fig.  1).  An analysis of the deduced 
primary structure of gp80 shows that the amino terminus has 
a stretch of hydrophobic amino acids, serving as the leader 
sequence. The first 19 amino acids are cleaved off in the ma- 
ture glycoprotein, which starts with Ala at the amino termi- 
nus (Stadler et al.,  1982). The deduced protein shows three 
major structural domains.  The carboxy-terminal region is 
composed of 18 hydrophobic amino acids, which is a poten- 
tial membrane-spanning domain.  Adjacent to the carboxy- 
terminal domain is  a  hydrophilic region,  located between 
amino acid positions 431 and 496. Within this domain is a 
unique Pro-rich segment, which contains two 8-amino acid- 
repeats. Since many of the amino acids in this domain have 
high probabilities for turns, it may take the form of a rela- 
tively rigid stalk structure. The third domain consists of the 
amino-terminal 434 amino acids. This domain is character- 
ized by many short stretches of hydrophobic segments alter- 
Figure 2. gp80 cDNA inserts cloned into the pRIT2T expression 
vector. Three different gp80 cDNA inserts were fused in frame to 
the carboxyl-terminal coding region of the protein A gene as de- 
scribed in Materials and Methods. The protein A gene codes for 
a 31-kD polypeptide. 
Figure 3. Gel profiles of pro- 
tein  A/gp80 fusion  proteins. 
Transformants  carrying  the 
different gp80 inserts were in- 
duced to produce the protein 
A/gp80 fusion protein. Fusion 
proteins were purified by two 
passages  through  an  IgG- 
Sepharose affinity  column and 
samples  were  analyzed  by 
SDS-PAGE. The slab gel was 
subjected  to  silver  staining. 
Lanes A, B, and C are PA80I, 
PAS011, and PASOIII, respec- 
tively.  Values given  to  the 
right of the gel lanes represent 
Mr in kD. 
nated by hydrophilic residues and it may have a highly folded 
globular structure. There are five potential N-glycosylation 
sites within this domain. 
Expression and Purification of  Fusion Proteins 
We have recently found that the cell adhesion-blocking mAb 
80L5C4 recognizes an epitope in the amino-terminal domain 
of gpS0 between amino acid residues 123 and 173 (Kamboj 
and Siu,  1988). It is, therefore, likely that the cell binding 
site of gp80 resides in the close vicinity of this epitope. To 
test this hypothesis, gene fusions containing three different 
cDNA fragments were constructed using the expression vec- 
tor pRIT2T  (Fig.  2).  These gp80  cDNA  fragments  were 
cloned into the unique Eco RI site of pRIT2T. Transformants 
carrying these recombinant plasmids produced soluble fu- 
sion  proteins  which  contained  the  amino-terminal  31-kD 
fragment of Staphylococcal protein A and a portion of the 
gp80 polypeptide. The plasmid carrying insert I (Eco RI to 
Eco RI fragment) coded for a protein A/gp80 fusion protein 
(PA80I) of 74 kD, which contained a gpS0 fragment between 
amino acid residues 123 and 514 (Fig. 3). Transformants car- 
rying insert II produced a fusion protein (PASOII) of 46 kD, 
which contained a gp80 fragment between residues 123 and 
258.  Those carrying insert  III produced a  fusion protein 
(PASOIII) of 68 kD,  which contained a gpS0 fragment be- 
tween residues 174 and 514. When subjected to immunoblot 
analysis,  both  PA80I  and  PA80II  reacted  with  the  mAb 
80L5C4, while PA80III reacted with a polyclonal antibody 
but not 80L5C4 (data not shown). 
To purify these three fusion proteins for further character- 
ization, cell lysates were passed twice through an IgG-Seph- 
arose  affinity  column.  The  purified  protein  preparations 
were subjected to SDS-PAGE analysis and the silver-stained 
gel profiles were shown in Fig.  3.  Only slight degradation 
was  observed in  these preparations and  all three samples 
showed major bands corresponding closely to the expected 
molecular sizes of the three protein A/gp80 fusion proteins. 
Binding of  Fusion Proteins to Intact Cells 
To test whether the fusion proteins have cell-binding activity, 
they were radioiodinated and assayed for their ability to bind 
to aggregation stage cells. Fusion protein samples were solu- 
bilized in 0.1% octyl glucoside before use.  Cells were in- 
cubated with the  125I-labeled fusion protein at 4°C  for 45 
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Figure  4.  Binding  of fusion proteins  to aggregation  stage  cells. 
Purified fusion proteins were dialyzed against 0.1% octyl glucoside 
and labeled  with  125I using chloramine T. NC4 cells were devel- 
oped in liquid medium for 10 h and then collected  for the binding 
assay.  Cells  were washed  and resuspended  in 5 mM EDTA and 
phosphate  buffer at 5  x  106 cells/ml.  Cells samples  (0.1 ml) were 
incubated with different amounts of ~25I-labeled protein for 45 min 
at 4°C. Nonspecific background binding was estimated by the bind- 
ing of different concentrations of t25I-labeled protein A (sp act, 5.1 
x  104 cpm/ng) to similar cell samples and the amount bound was 
substracted from the corresponding samples.  (e) PA80I (sp act, 2.4 
x  104 cpm/ng); (o) PA80II (sp act, 5.0  x  104 cpm/ng); and (B) 
PA80III (sp  act,  2.6  x  104 cpm/ng).  Assays were performed in 
triplicate  and the means  +  SD were plotted. 
min in the presence of 5 mM EDTA to slow down the kinetics 
of  cell  reassociation  and  thus  minimize  the  extent  of 
nonspecific trapping.  Background binding due to protein A 
was also estimated by incubating cell samples with different 
concentrations  of 125I-labeled  protein  A.  After subtracting 
the background binding  from each corresponding sample, 
the amount of fusion protein bound per cell was estimated 
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Figure  5.  Inhibition of fusion protein binding  to intact  cells  by 
80L5C4 IgG. Aggregation stage cells  (10 h) were resuspended  at 
2  x  107 cells/ml  in phosphate buffer containing 5 mM EDTA and 
then precoated with different concentrations of 80L5C4 IgG at 10 
pg/ml  for  15  min at 4°C.  Cells  were  resuspended  at  5  x  106 
cells/ml  in the same buffer containing 0.25 mg/ml goat anti-mouse 
IgG Fab before  the addition of ~25I-labeled fusion protein  (2 pg/ 
ml).  The rest of the binding assay was carried out as described in 
Fig.  4.  (e) PA80I; (o) PA80II; and  (---) gp80.  Values represent 
means  -t- SD with n  =  3. 
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Figure 6. Inhibition  of cell-cell adhesion by fusion proteins.  Cells 
were developed  on filter pads  for 10 h and then collected  for the 
cell cohesion assay. Cells were suspended  at 2.5  ×  106 cells/ml  in 
10 mM EDTA/phosphate  buffer. At 0 rain,  either octyl glucoside 
or fusion protein was added and the sample was vortexed briefly to 
disperse all aggregates.  Samples (0.2 ml) were rotated vertically  at 
180 rpm and reassociation  of cells was monitored microscopically 
at regular intervals.  (A) Cells were reassociated  in the presence of 
50 I.tg/ml PA80I (,),  50 pg/ml PASOII  (o),  or 50 pg/ml PA80III 
(i).  (A) Control sample  reassociated  in the presence of 0.005% 
octyl glucoside.  (B) Cell samples were reassociated  in the presence 
of different concentrations  of PA80I (e) or PA80II (o).  The data 
were taken  from the 45-min point. 
(Fig. 4). The binding of fusion proteins PA80I and PA80II to 
cells were both dosage dependent and saturable. The number 
of molecules bound per cell was estimated to be  1.7  ×  1@ 
and  1.6  x  1@ for PA80I and PA80II, respectively.  On the 
other  hand,  the  binding  of PA80III was  essentially  at  the 
background level. The data thus indicate that the cell-binding 
domain is retained in PA80I and PA80II but not in PA80III 
and probably resides within the segment between Vail23 and 
Leu173. 
To further characterize the cell-binding activity of PA80I 
and  PA80II, we tested  whether  they bound  specifically to 
gp80 molecules  on the cell  surface.  Cells  were precoated 
with different amounts of the anti-gp80 mAb 80L5C4 before 
carrying  out  the  binding  assay  with  fusion  proteins.  The 
binding of ~25I-labeled  PA80I or PA80II was  inhibited  in a 
dosage-dependent  manner  (Fig.  5).  In  both  cases,  the 
amount of IgG required to achieve 50 % inhibition was within 
a  twofold difference in comparison with  the control using 
tzSI-labeled gp80 for binding. These results indicate that the 
binding of PA80I and PA80II to cells is similar to that of solu- 
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Figure 8. Inhibition of cell reassociation by anti-PA80II antibody. 
Aggregation stage cells were incubated with the anti-PA80II antise- 
rum (1:20 dilution) and then resuspended in goat anti-rabbit IgG 
Fab at 2.5  x  106 cells/ml.  Samples were rotated at 180 rpm on a 
platform shaker for cell reassociation.  (o) Sample precoated with 
the anti-PA80II antibody; (4) control sample precoated with pre- 
immune rabbit serum. 
Figure 7. Phase micrographs of cells reassociated in the presence 
or absence of fusion proteins. 10-h cells were reassociated in EDTA 
phosphate buffer as described in Fig. 6 and phase micrographs were 
taken at 30 min of reassociation.  (a) Cells reassociated in 0.005 % 
octyl glucoside, (b) cells reassociated in 100 ~tg/ml PA80I, and (c) 
cells reassociated in 50 I.tg/ml PA80II. Bar, 20 ~tm. 
ble  gp80  to  surface-associated gp80  on  aggregation  stage 
cells. 
Effect of Fusion Proteins on Cell-CeU Adhesion 
If both fusion proteins PA80I and PA80II exist in monomeric 
form in  solution  and each monomer consists  of only one 
gp80 binding  site, binding of either fusion protein to cells 
should block cell-cell adhesion mediated by the homophilic 
interaction between membrane-associated gp80 molecules. 
This was tested by incubating aggregation stage cells with 
different  concentrations  of detergent  solubilized  PA80I  or 
PA80II before performing the cell cohesion assay. Cell reas- 
sociation was significantly inhibited in the presence of either 
fusion protein at 50 Ixg/ml (Fig. 6A). However, the inclusion 
of PA80III at  the  same concentration  had  no  appreciable 
effect on cell reassociation. The control in which ceils were 
incubated  with  an  equivalent  amount  of  octyl  glucoside 
showed the normal kinetics of reassociation. The inhibitory 
effect of both fusion proteins PA80I and PA80II was dosage 
dependent (Fig. 6B). At 100 Ixg/ml of PA80I or 50 ktg/ml of 
PA80II, ,x~60% of the cells failed to reform aggregates and 
their effect was halved at 20  ~tg/ml and  10 Ixg/ml,  respec- 
tively. Since the molecular mass of PA80I was ~60% higher 
than  that  of PA_80II, the  molar concentrations  required  to 
achieve 50% inhibition were quite comparable for these two 
fusion proteins.  The effect of both fusion proteins became 
negligible at a concentration of 1 lag/ml. 
The morphology of cell aggregates formed in the presence 
of PA80I and PA80II was quite different from that of the con- 
trol (Fig. 7). Aggregates formed in the control sample were 
indistinguishable from those formed in the absence of deter- 
gent, while most of the aggregates were significantly smaller 
in samples incubated with the fusion protein. 
Inhibition of CeU-CellAdhesion by 
Anti  fusion Protein Antibody 
The observation that the fusion protein PA80II was able to in- 
hibit  cell  reassociation  suggests  that  it  contains  the  cell- 
binding  site  of gp80.  It  is,  therefore,  of  interest to  test 
whether antibodies directed against PA~80II would have any 
effect on cell aggregation.  Antibodies against PA80II were 
raised in rabbit and added to aggregation stage cells before 
the  cohesion  assay.  Cell  reassociation  was  inhibited  by 
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Figure  9.  Competition of ~25I-gp80 binding to immobilized gp80 
by fusion proteins. Samples of 0.1 lag native gp80 were immobilized 
on nitrocellulose disks. After blocking with 5 % skin milk in PBS, 
the disks were incubated with different molar ratios of ~25I-labeled 
gp80  (sp act,  1.2  x  104 cpm/ng)  and unlabeled  fusion protein, 
with the labeled gp80 kept constant at 200 ng/ml. Background bind- 
ing was estimated by the inclusion of a blank disk in the incubation 
mixture and subtracted from the bound radioactivity on the corre- 
sponding sample disk. Competitive inhibition was carried out with 
PA80I (o), PA80II (o), protein A (m), and gp80 (---). Samples 
were done in triplicate and the means  +  SD were plotted.  In the 
control where no competitor was added, the amount of radioactivity 
bound was 1.1  x  105cpm. 
~70%  in the presence of the antibody (Fig.  8).  The result 
is consistent with the notion that the gp80 fragment in PA80II 
has cell-binding activity. 
Competition of USl-labeled gp80 Binding to 
lmmobilized gp80 by Fusion Protein 
To provide direct evidence that fusion proteins PA80I  and 
PA80II can indeed bind to gp80, an in vitro filter binding as- 
say was used to test their ability to compete for gp80 binding. 
We  have  previously  demonstrated  that  J25I-labeled  gp80 
binds quantitatively to gp80 immobilized on nitrocellulose 
filter and the binding can be competed offby a 50- to 100-fold 
excess of cold gp80 (Siu et al.,  1987).  Similar studies were 
carried out using either PA80I or PA80II as the competitor 
and the results are shown in Fig. 9. A 70-fold excess of PA80I 
or a 200-fold excess of PA80II was required to achieve 50% 
competition. In comparison, native gp80 achieved the same 
extent of competition at 25-fold excess, while protein A did 
not have significant  inhibitory  effect on gp80-gp80  inter- 
action. 
Homophilic Binding of  Fusion Protein PA80II 
It is, therefore, evident that the cell-binding site of gp80 is 
located within the gp80 fragment of PA80II. It remained to 
be determined whether PA80II was interacting with a recep- 
tor element in the same region or in a different part of gp80. 
To resolve this, the ability of J25I-labeled PA80II to bind to 
PA80II immobilized on nitrocellulose disks was assayed. For 
comparison, approximately equal molar amounts of protein 
A, PA80I,  PA80III, and gp80 were immobilized separately 
on nitrocellulose disks for binding with 125I-labeled PAS011. 
o 
< 
3  - 
1 
0  2  4  6 
125 I-PA8011  (pg/ml) 
Figure 10. Homophilic interaction of PAII. Samples of  0.1 lag PA80II 
(o), 0.2 ~tg PA80I (o), 0.2 Ixg gp80 (A), 0.2 gg PA80III (B), or 0.1 
lag protein A (D) were immobilized on nitrocellulose disks. Filter 
binding assays were carried out in triplicate with different concen- 
trations  of J25I-labeled PA80II (sp act,  5  x  l04 cpm/ng)  as de- 
scribed in Materials and Methods. Values represent means +  SD. 
Fig.  10 shows that PA80II was able to undergo homophilic 
binding  with  immobilized  PA80II  in  a  dosage-dependent 
manner  and  the  binding  was  saturable.  Almost  identical 
binding curves were obtained for both PA80I and gp80 (Fig. 
10)  indicating that essentially the same number of PA80II 
molecules were bound in each case. However, the binding of 
labeled PA80II to immobilized PA80III was essentially at the 
background level, similar to results with bound protein A. 
Discussion 
Full length cDNAs for the cell-cell adhesion molecule gp80 
were isolated and sequenced. An analysis of the gp80 eDNA 
sequence  shows many characteristics common to other D. 
discoideum genes (Kimmel and Firtel, 1983). The coding re- 
gion makes use of mainly codons with either an A or T  in 
the third base. The 5' and 3' flanking regions are character- 
ized by homopolymers of A and T. Since we have obtained 
several clones with recombined fragments at either 5' or 3' 
ends of the insert,  recombination between different eDNA 
fragments probably occurs frequently at these poly-A tracks. 
Our eDNA sequence for gp80 is similar but not identical 
to that reported by Noegel et al. (1986). In the coding region, 
differences are located at nucleotide positions 480 (G), 647 
(T),  773  (C),  774  (T),  779  (C),  and 780  (T),  which they 
reported T, G, T, C, T, and C, respectively. These differences 
would result in three amino acid changes, involving Val, Ala, 
and Gly. In addition, our sequence upstream from nucleotide 
position  -39  is  completely  different  from  the  one  they 
reported. We have obtained identical sequences from two in- 
dependently isolated inserts of different sizes. Our eDNA se- 
quence has also been confirmed by sequencing the genomic 
DNA for gp80 (Lam, T. Y., and C.-H. Siu, unpublished ob- 
servations).  While  our  sequence  is  extremely  AT  rich 
(95%), theirs is relatively GC rich (40%), which is typical 
of a  coding  sequence  and  thus  might have resulted  from 
recombining  with  another  eDNA  fragment at the  poly-A 
track beginning at nucleotide position  -39. 
We have made use of the expression vector pRIT2T which 
allowed us to obtain protein A/gp80 fusion proteins in solu- 
ble form. Previous attempts using other expression vectors 
have often resulted in the precipitation of the fusion protein, 
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ies. Another advantage of this vector is that protein A/gp80 
fusion proteins can be easily purified by passage over an IgG- 
affinity  column. Although some degradation was observed in 
these preparations,  the cell-binding activity of the fusion 
protein appeared to be relatively stable. 
Several in vitro binding assays have been performed with 
three protein A/gp80 fusion proteins. Since all three fusion 
proteins harbor either the cell-binding site or the hydropho- 
bic carboxy-terminal  region of gp80, they have a tendency to 
aggregate in the absence of detergent. Prior treatment with 
a mild detergent is necessary for all the assays.  Two of the 
fusion proteins, PASOI and PASOII, can bind to aggregation 
stage  cells.  In  both  cases,  1.6-1.7  x  106  molecules  are 
bound per cell. This value agrees closely with the number 
of gp80 molecules expressed on cells at this stage (Siu et al., 
1988a).  The binding of PA80I and PA80II to cells is inhibited 
by precoating cells with the mAb 80L5C4, supporting the 
idea that both fusion proteins are interacting with gp80 mole- 
cules on the cell surface. The binding of either one of these 
two fusion proteins to aggregation stage cells has an inhibi- 
tory effect on cell reassociation. This is consistent with the 
notion that PA80I and PA80II are competing for the cell- 
binding site on gp80. 
Both PA80I and PA80II are capable of competing for gp80 
binding in the filter binding assay. Despite the fact that PA80I 
contains only part of the gp80 protein moiety, native gp80 
is only two to three times more effective than PA80I. Even 
in the case of PA80II,  a molar ratio that is only eightfold 
higher than native gp80 is required to achieve 50% competi- 
tion. Since PA80II contains a much shorter fragment ofgp80 
than PA80I, it is conceivable that the conformation of its cell- 
binding domain is less stable, resulting in a lower concentra- 
tion of molecules with the proper gp80-binding site and thus 
a lower apparent affinity for native gp80. The protein A por- 
tion of these fusion proteins might also contribute a certain 
amount of steric hindrance to the cell-binding domain. 
Results of the binding studies lead to the mapping of a cell- 
binding domain in gp80 to a 51 amino acid region between 
residues 123 and 173. It is of interest to note that it corre- 
sponds exactly to the region which harbors the 80L5C4 epi- 
tope  (Kamboj  and Siu,  1988).  Since the anti-gp80  mAb 
80L5C4 is a potent inhibitor of cell-cell adhesion, it is likely 
that 80L5C4 IgG recognizes this cell-binding site or an epi- 
tope close to it. The region between Vail23 and Leu173 con- 
sists of a hydrophilic stretch of amino acids followed by a 
relatively hydrophobic  segment.  There  are  two  potential 
N-glycosylation sites within this region. Therefore, this part 
of the gp80 molecule is most likely exposed to the surface, 
allowing it to participate directly in cell-cell binding. Al- 
though the precise mechanism of homophilic binding be- 
tween two gp80 molecules is not known, our data suggest 
that the major binding force is contributed by protein-pro- 
tein interaction. Future studies focusing on smaller segments 
of this region should lead to a better understanding of the 
binding mechanism. 
Since PA80II contains the smallest gp80 fragment, it was 
used to determine whether its binding site recognizes one or 
more receptor elements on gp80. PASOII binds equally well 
with immobilized PA_80I, PA80II,  and gp80,  but not with 
PA80III. It is, therefore, evident that PA80II binds to a single 
site on gp80 and that the homphilic binding site of gp80 is 
also  located  between  Vail23  and  Leu173.  Since  labeled 
PASOHI does not bind gp80 (Kamboj, R., and C.-H. Siu, un- 
published results), it precludes the presence of another bind- 
ing site between I1e174 and I1e514. 
We have previously proposed three different models for 
gp80-gp80 interaction (Siu et al.,  1987).  One of them re- 
quires direct protein-protein interaction, while the other two 
involve the participation of oligosaccharide(s) in the binding 
activity. The fact that soluble PA80II is capable of undergo- 
ing homophilic binding with immobilized PA80II (Fig.  10) 
clearly demonstrates that the cell-binding site mapped be- 
tween Vail23  and  Leu173  is one  that involves  only pro- 
tein-protein interaction. Our results suggest that there are no 
other protein-protein interacting sites on gp80, but they do 
not rule out the possibility of a second binding site involving 
protein-carbohydrate interaction. 
The role of carbohydrate in gp80 function in vivo is still 
an unsettled issue, gp80 has two types of N-linked oligosac- 
charides. Type 1 is heavily sulfated while type two is not 
(Hohmann et al.,  1985).  Type 2 carbohydrate is immuno- 
dominant and many of the reported anti-gp80 antibodies are 
directed against it. Several mAb that belong to this class ex- 
hibit inhibitory effect on cell reassociation (Ochiai et al., 
1982a;  Siu et al.,  1985;  Springer  and Barondes,  1985). 
Therefore, the type 2 carbohydrate of gp80 has been impli- 
cated in mediating cell-cell adhesion. The role of type 2 car- 
bohydrate in gp80 has been reevaluated recently using strains 
with mutations in the modB locus, which affects a posttrans- 
lational  modification of certain  membrane glycoproteins. 
Mutations in this locus result in the loss of the type 2 carbo- 
hydrate in gp80 (Murray et al.,  1984) and mutant cells ac- 
cumulate a mutant gp80 of lower molecular size (Gerisch et 
al., 1985; Siu et al., 1985).  The amount of gp80 expressed 
in these mutant cells is considerably lower than that of the 
parental strain (Siu and Lam, 1988). However, they are capa- 
ble  of forming EDTA-resistant  binding sites and undergo 
normal  morphogenesis.  Cell-cell  adhesion  among  modB 
mutants can be blocked by the mAb 80L5C4 (Siu and Lam, 
1988).  These observations are consistent with the idea that 
the cell-binding activity of gp80 resides in its protein moiety 
and that the type 2 carbohydrate does not directly participate 
in cell-cell adhesion. Since the cell-binding domain poten- 
tially has two oligosaccharide side chains, it is conceivable 
that binding of immunoglobulin molecules to carbohydrate 
epitopes in this region would sterically hinder the cell-bind- 
ing activity. 
Although it is evident that the cell-binding activity of gp80 
resides in the protein moiety and not the carbohydrate moi- 
ety, treatment of cells with tunicamycin, which inhibits N-gly- 
cosylation, has been found to block cell-cell adhesion (Lam 
and Siu, 1982; Ochiai et al.,  1982b;  Yamada et al.,  1982). 
Hirano  et  al.  (1983) found that  EDTA-resistant  cell-cell 
binding sites  in tunicamycin-treated cells can be  restored 
when tunicamycin is added in the presence of the protease 
inhibitor leupeptin. It is, therefore, likely that the involve- 
ment of this carbohydrate moiety in cell adhesion is indirect 
in that it acts to protect the protein moiety of gp80 from pro- 
teolytic degradation (Hirano et al.,  1983;  Hohmann et al., 
1987). Since the type 1 carbohydrate of gp80 is heavily sul- 
fated (Hohmann et al., 1985), it is conceivable that they may 
play a modulatory role in cell-cell adhesion similar to the 
model proposed for the neural cell adhesion molecule (Edel- 
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ther evaluated when specific antibodies directed against it be- 
come available. 
In addition to gpS0,  another glycoprotein (gp69/73)  has 
been  implicated  in  mediating  the  EDTA-resistant  type  of 
cell-cell adhesion (Brodie et al.,  1983).  It is possible that 
several  separate  but  interdependent  adhesion  systems  are 
operating at the aggregation stage of development. In this re- 
gard, it is of interest to note that endoglycosidase H-resistant 
glycopeptides derived from 8-h cells are able to inhibit  the 
reassociation of aggregation stage cells (Ziska and Hender- 
son,  1988).  Since these glycopeptides were derived from a 
mixture of plasma membrane glycoproteins, their relation- 
ship to gp80 or gp69/73 remains to be clarified. It is also pos- 
sible that these glycopeptides may belong to a cell adhesion 
molecule yet to be identified. The purification and character- 
ization of these molecules will be important to our future en- 
deavor to dissect the complex phenomenon of cell-cell inter- 
action. 
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